Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-07-07 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于原5%以上股东股份计划减持时间过半的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the methods of reduction, dates, and compliance with relevant regulations. There is no financial data, earnings information, or report attached. The content fits the definition of a Major Shareholding Notification, as it informs about changes in significant share ownership levels.
2023-07-07 Chinese
2023年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the half-year period ending June 30, 2023, indicating expected profit growth and earnings per share. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the company's 2023 half-year report. The document is relatively short (761 characters) and serves as a preliminary earnings forecast rather than a full interim or quarterly report containing actual financial statements. Therefore, it is best classified as an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. H1 2023
2023-07-07 Chinese
关于控股子公司获得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining a drug registration certificate from the national drug regulatory authority. It includes details about the drug, its approval, and the potential impact on the company. The document is short (905 characters) and serves as a formal announcement of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or detailed governance information. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about a significant company event that does not fit other specific categories.
2023-07-05 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2022 annual profit distribution (dividend) plan approved at the 2022 annual general meeting held on May 18, 2023. It details the dividend amount per share, the record date, the ex-dividend date, and the method of dividend payment. It also references the approval by the shareholders and the board meeting resolutions. The document is relatively short (1951 characters) and focuses on the dividend distribution details rather than presenting a full financial report or annual report. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2023-07-04 Chinese
关于控股子公司2023年度第五期超短期融资券发行结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the issuance results of a short-term financing bond by a subsidiary of the company. It includes details such as issuance amount, interest rate, dates, and registration information. There is no financial statement or comprehensive financial report content. The document is a financing update about capital raising activities, specifically the issuance of short-term bonds. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and focused on financing details, not a full report or regulatory filing.
2023-06-28 Chinese
北京中伦（成都）律师事务所关于重药控股股份有限公司终止2020年限制性股票激励计划暨回购注销限制性股票实施情况的法律意见书
Audit Report / Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the termination of a 2020 restricted stock incentive plan and the repurchase and cancellation of restricted shares by the company. It includes detailed legal verification and procedural compliance statements, but it is not a financial report or earnings release. It is a standalone legal opinion related to a specific corporate action (stock repurchase and cancellation). The document length is 3776 characters, which is relatively short and focused on legal matters. This fits best under the category of Audit Report / Information (AR), as it is a specialized legal audit/opinion on a corporate action, not a full annual or interim report, nor a simple announcement. It is not a Regulatory Filing (RNS) because it contains substantive legal opinion content rather than a brief announcement or certification. Therefore, the classification is AR with high confidence. Q2 2023
2023-06-13 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.